Clinical trials data
Symbol Coding in sleep trials: 89 registered studies
Every registered sleep and sleep disorders study on ClinicalTrials.gov that names Symbol Coding in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered sleep and sleep disorders studies name it in an outcome measure
- 89
- Name it in a primary outcome, 33%
- 29 of 89
Tests named in the same studies
- 1
Psychomotor Vigilance Task35 studies, 21 as a primary outcome
- 2
Trail Making Test18 studies, 6 as a primary outcome
- 3
N-Back Task14 studies, 12 as a primary outcome
- 4
Verbal Learning12 studies, 3 as a primary outcome
- 5
Digit Span Test11 studies, 4 as a primary outcome
- 6
Stroop Color-Word Test10 studies, 3 as a primary outcome
- 7
Verbal Fluency8 studies, 3 as a primary outcome
- 8
Balloon Risk6 studies, 4 as a primary outcome
- 9
Paced Visual Serial Addition Test6 studies, 4 as a primary outcome
- 10
Selective Reminding Task6 studies, 0 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 5 | 0 |
| 2005 | 2 | 0 |
| 2006 | 1 | 1 |
| 2007 | 4 | 0 |
| 2008 | 3 | 1 |
| 2009 | 4 | 0 |
| 2010 | 3 | 0 |
| 2011 | 2 | 1 |
| 2012 | 1 | 0 |
| 2013 | 3 | 0 |
| 2014 | 0 | 0 |
| 2015 | 3 | 2 |
| 2016 | 2 | 1 |
| 2017 | 4 | 1 |
| 2018 | 5 | 4 |
| 2019 | 7 | 3 |
| 2020 | 4 | 3 |
| 2021 | 4 | 2 |
| 2022 | 6 | 1 |
| 2023 | 5 | 3 |
| 2024 | 9 | 3 |
| 2025 | 4 | 2 |
| 2026 | 7 | 1 |
Phases and study sizes
By phase
- Phase 14 studies, 2 as a primary outcome
- Phase 212 studies, 2 as a primary outcome
- Phase 313 studies, 0 as a primary outcome
- Phase 48 studies, 2 as a primary outcome
- Not applicable42 studies, 18 as a primary outcome
- Observational10 studies, 5 as a primary outcome
Participants per study
- Phase 267 median, 44 to 126
- Phase 391 median, 40 to 309
- Not applicable59 median, 25 to 120
- Observational85 median, 53 to 100
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 11 | 67 | 44 to 126 |
| Phase 3 | 13 | 91 | 40 to 309 |
| Not applicable | 41 | 59 | 25 to 120 |
| Observational | 10 | 85 | 53 to 100 |
When sleep trials measure it
Latest time point of each outcome
- Within a day12 outcomes, 3 as a primary outcome
- Up to 4 weeks31 outcomes, 12 as a primary outcome
- 1 to 3 months15 outcomes, 2 as a primary outcome
- 3 to 6 months6 outcomes, 2 as a primary outcome
- 6 to 12 months7 outcomes, 4 as a primary outcome
- 1 to 2 years2 outcomes, 1 as a primary outcome
- No duration given16 outcomes, 5 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
73 of the 89 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting12 studies, 4 as a primary outcome
- Not yet recruiting5 studies, 2 as a primary outcome
- Active, not recruiting6 studies, 3 as a primary outcome
- Completed54 studies, 19 as a primary outcome
- Stopped early4 studies, 0 as a primary outcome
- Status unknown8 studies, 1 as a primary outcome
What they test
- Behavioral15 studies, 8 as a primary outcome
- Drug37 studies, 5 as a primary outcome
- Device14 studies, 3 as a primary outcome
- Dietary supplement3 studies, 1 as a primary outcome
- Diagnostic test2 studies, 2 as a primary outcome
- Radiation3 studies, 2 as a primary outcome
- Combination product1 studies, 1 as a primary outcome
- Other14 studies, 6 as a primary outcome
- None given5 studies, 2 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States35 studies, 8 as a primary outcome
- Singapore6 studies, 6 as a primary outcome
- Canada5 studies, 2 as a primary outcome
- United Kingdom5 studies, 1 as a primary outcome
- Germany4 studies, 1 as a primary outcome
- Brazil3 studies, 0 as a primary outcome
- Denmark3 studies, 1 as a primary outcome
- Norway3 studies, 0 as a primary outcome
- Sweden3 studies, 2 as a primary outcome
- Türkiye3 studies, 2 as a primary outcome
- France2 studies, 1 as a primary outcome
- Italy2 studies, 1 as a primary outcome
25 countries in all. A study with sites in several counts in each; 8 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed sleep and sleep disorders studies that name Symbol Coding: 30 of 54, 56%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed sleep and sleep disorders studies that name Symbol Coding | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 9, 17% | 776, 10% |
| Results on ClinicalTrials.gov only | 7, 13% | 1,139, 14% |
| A results paper only | 14, 26% | 1,711, 22% |
| Neither | 24, 44% | 4,327, 54% |
The 89 studies
89 studies match. 29 name Symbol Coding in a primary outcome. Median size 60 participants. Median time to the primary outcome: 2 weeks.
Loading 89 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 5 | 0 |
| 2005 | 2 | 0 |
| 2006 | 1 | 1 |
| 2007 | 4 | 0 |
| 2008 | 3 | 1 |
| 2009 | 4 | 0 |
| 2010 | 3 | 0 |
| 2011 | 2 | 1 |
| 2012 | 1 | 0 |
| 2013 | 3 | 0 |
| 2014 | 0 | 0 |
| 2015 | 3 | 2 |
| 2016 | 2 | 1 |
| 2017 | 4 | 1 |
| 2018 | 5 | 4 |
| 2019 | 7 | 3 |
| 2020 | 4 | 3 |
| 2021 | 4 | 2 |
| 2022 | 6 | 1 |
| 2023 | 5 | 3 |
| 2024 | 9 | 3 |
| 2025 | 4 | 2 |
| 2026 | 7 | 1 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 29, other 60. Interventional 79, observational 10.
As a primary outcomeSecondary or other outcomeSymbol Coding
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07897474 | Start2026 | PhaseObservational | ConditionsSleep and sleep disorders | Participants100 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07827651 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers, Aging, frailty and exercise, Sleep and sleep disorders | Participants64 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07799753 | Start2026 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants50 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07714772 | Start2026 | PhaseObservational | ConditionsParkinson's disease, Sleep and sleep disorders | Participants50 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07633392 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise, Substance use and addiction, Sleep and sleep disorders, Cardiovascular disease | Participants240 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07608614 | Start2025 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants16 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07555379 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis, Sleep and sleep disorders, Pain and fatigue | Participants40 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07542756 | Start2026 | PhasePhase 4 | ConditionsSleep and sleep disorders | Participants1,200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07426991 | Start2024 | PhaseObservational | ConditionsMultiple sclerosis, Sleep and sleep disorders, Pain and fatigue | Participants837 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07363720 | Start2026 | PhasePhase 3 | ConditionsSleep and sleep disorders | Participants98 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07118904 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants12 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06893224 | Start2024 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants60 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06773416 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise, Sleep and sleep disorders | Participants206 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06685341 | Start2019 | PhasePhase 1 | ConditionsSleep and sleep disorders | Participants20 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT06553235 | Start2024 | PhaseNot applicable | ConditionsCancer, Sleep and sleep disorders | Participants84 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06496282 | Start2024 | PhasePhase 3 | ConditionsSleep and sleep disorders | Participants50 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06266611 | Start2024 | PhasePhase 2 | ConditionsDepression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD, Pain and fatigue | Participants185 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06260254 | Start2024 | PhaseNot applicable | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants23 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06243172 | Start2024 | PhaseObservational | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06113666 | Start2023 | PhaseNot applicable | ConditionsMultiple sclerosis, Sleep and sleep disorders, Pain and fatigue | Participants550 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06052514 | Start2024 | PhaseObservational | ConditionsSleep and sleep disorders, COVID-19 and long COVID | Participants22 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06032377 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD | Participants275 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05956392 | Start2023 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants150 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05775627 | Start2023 | PhaseNot applicable | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05611619 | Start2023 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants45 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many sleep trials use Symbol Coding?
89 registered sleep and sleep disorders studies on ClinicalTrials.gov name it in an outcome measure, 29 of them in a primary outcome: 12% of the condition's 749 studies with a cognitive outcome, against 9% of all of them. It is the 3rd most named test in sleep trials.
Which tests do sleep trials use with Symbol Coding?
The Psychomotor Vigilance Task (35 studies), the Trail Making Test (18 studies) and the N-Back Task (14 studies).
How many participants do phase 2 sleep trials that use Symbol Coding enroll?
Half of the phase 2 studies that name it enroll 67 participants or fewer, and the middle half enroll 44 to 126. 11 of them give a size.
When do sleep trials measure Symbol Coding?
Half of the primary outcomes that name Symbol Coding are measured within 2 weeks of the start, and the middle half from 1 week to 4 months. 24 primary outcomes give a duration.
How many completed sleep trials that use Symbol Coding have reported results?
30 of the 54 completed studies that name it, 56%, have reported results: 16 posted them on ClinicalTrials.gov, 23 have a results paper linked to the registry record, and 9 did both. The other 24 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Symbol Key Game and Symbol Coding as one test family, so this page counts their studies together.
Run Symbol Coding in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.